MedTrace Logo

Rapid Detection of COVID-19 by Portable and Connected Biosensor

NCT04367142 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2024-12-17

No results posted yet for this study

Summary

The objective of study is to estimate the sensitivity and specificity of the COR-DIAL based on nasopharyngeal samples taken at the patient's admission in relation to the final diagnosis of COVID-19 made by the medical team.

Conditions

  • Sars-CoV2

Interventions

DIAGNOSTIC_TEST

COVID-19 RT-PCR

Nasopharyngeal swabs for COVID-19 RT-PCR

DIAGNOSTIC_TEST

Biosensor

Portable and Connected Biosensor viral

Sponsors & Collaborators

  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • Enagnon Kazali ALIDJINOU, MD · University Hospital, Lille

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-24
Primary Completion
2023-05-02
Completion
2023-05-02

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04367142 on ClinicalTrials.gov